457 Preclinical pharmacology of AZD5312, a generation 2.5...

European Journal of Cancer 2014 / 11 Vol. 50

457 Preclinical pharmacology of AZD5312, a generation 2.5 antisense oligonucletotide targeting the androgen receptor with differentiated activity from enzalutamide

Davies, B.R., Thomason, A., Ellston, R., Campbell, H., D'Cruz, C., Mazzola, A.M., Zhou, T., Schmidt, J., Jo, M., Kim, Y., McLeod, A.R., Blakey, D., Brooks, N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70583-0
Date:
November, 2014
File:
PDF, 54 KB
english, 2014
Conversion to is in progress
Conversion to is failed